Experimental drugs in clinical trials for COPD: artificial intelligence via machine learning approach to predict the successful advance from early-stage development to approval-Reference-Cited by-同舟云学术

Experimental drugs in clinical trials for COPD: artificial intelligence via machine learning approach to predict the successful advance from early-stage development to approval

Published:2023-06-03 Issue:6 Volume:32 Page:525-536
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

Calzetta Luigino¹^ORCID,Pistocchini Elena²,Chetta Alfredo¹,Rogliani Paola²^ORCID,Cazzola Mario²

Affiliation:

1. Department of Medicine and Surgery, University of Parma, Parma, Italy

2. Department of Experimental Medicine, University of Rome “Tor Vergata”, Rome, Italy

Funder

MUR-PNRR M4C2I1.3 PE6

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543784.2023.2230138

Reference95 articles.

1. 2023 Gold reports - global initiative for chronic obstructive lung disease - gold [Internet]. [cited 2022 Mar 14]. Available from: https://goldcopd.org/2023-gold-report-2/#.

2. Effect of Aminophylline on Respiratory-Center Sensitivity in Cheyne-Stokes Respiration and in Pulmonary Emphysema

3. Nebulization of N-Acetylcysteine Combined with a Bronchodilator in Patients with Chronic Bronchitis

4. Controlled Clinical Trial of Methylprednisolone in Patients with Chronic Bronchitis and Acute Respiratory Insufficiency

5. Azithromycin for Prevention of Exacerbations of COPD

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ensifentrine approval: A milestone in the treatment of COPD;Pulmonary Pharmacology & Therapeutics;2024-12

2. Pharmacological Interpretation of the Efficacy of Ensifentrine in Chronic Obstructive Pulmonary Disease: Insights from ENHANCE Trials;American Journal of Respiratory and Critical Care Medicine;2024-01-15

3. Artificial Intelligence in Chronic Obstructive Pulmonary Disease: Research Status, Trends, and Future Directions -A Bibliometric Analysis from 2009 to 2023;INT J CHRONIC OBSTR;2024

4. The novel inhaled dual PDE3 and PDE4 inhibitor ensifentrine for the treatment of COPD: A systematic review and meta-analysis protocol on trough FEV1 and exacerbation according to PRISMA statement;Current Research in Pharmacology and Drug Discovery;2024

5. Use of human airway smooth muscle in vitro and ex vivo to investigate drugs for the treatment of chronic obstructive respiratory disorders;British Journal of Pharmacology;2023-12-20